Pera Manuel
Institute of Digestive Diseases, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, University of Barcelona Medical School, Villarroel 170, Barcelona 08036, Spain.
World J Surg. 2003 Sep;27(9):999-1008; discussion 1006-8. doi: 10.1007/s00268-003-7052-2. Epub 2003 Aug 18.
Most available information on the epidemiology of Barrettacute;s esophagus (BE) relates to patients with long segments (> 3 cm) of specialized intestinal metaplasia (SIM). Its prevalence is 3% in patients undergoing endoscopy for reflux symptoms and 1% in those undergoing endoscopy for any clinical indication. The latter prevalence is similar to the 1% found in autopsy series. A "silent majority" with BE remain unrecognized in the general population. BE is more common in men, and the prevalence rises with age. Recent endoscopic series document a rise in the diagnosis of endoscopically apparent short segments (< 3 cm) of BE (SSBE). The prevalence of SSBE in both unselected and reflux patients is 8% to 12%. Specialized intestinal metaplasia at the cardia, below a normal-appearing squamocolumnar junction, has been reported to vary from 6% to 25% in patients presenting for upper endoscopy. Unlike patients with long segment Barrett's esophagus (LSBE), the role of gastroesophageal reflux disease in the pathogenesis of SSBE and SIM of the cardia is controversial. Recent data suggest that the etiology of SIM of the cardia might be secondary to Helicobacter pylori infection, although the role of other environmental factors cannot be ruled out. The incidence of adenocarcinoma of the esophagus and esophagogastric juction (EGJ) has been increasing over the past 15 years in Western countries. Surgical series and population-based studies show that by 1994 adenocarcinomas of the esophagus accounted for half of all esophageal cancer among white men. LSBE and SSBE predispose to the development of adenocarcinoma of the esophagus and EGJ. The role of SIM of the cardia as a precursor lesion for EGJ adenocarcinoma is still unclear. The prevalences of dysplasia in LSBE and SSBE are around 6% and 8%, respectively. The incidence of adenocarcinoma in patients with LSBE is about 1 in 100 patient-years. Cancer risk for SSBE and SIM at the cardia is unknown. Smoking and obesity increase the risk for esophageal and EGJ adenocarcinomas.
大多数关于巴雷特食管(BE)流行病学的现有信息都与患有长段(> 3 cm)特殊肠化生(SIM)的患者有关。在内镜检查以评估反流症状的患者中,其患病率为3%;在内镜检查用于任何临床指征的患者中,患病率为1%。后一种患病率与尸检系列中发现的1%相似。普通人群中存在着未被识别的BE“沉默多数”。BE在男性中更为常见,且患病率随年龄增长而上升。最近的内镜检查系列记录显示,内镜下可见的短段BE(SSBE,< 3 cm)的诊断有所增加。在未经选择的患者和反流患者中,SSBE的患病率为8%至12%。据报道,在接受上消化道内镜检查的患者中,贲门处正常外观的鳞柱状交界处下方的特殊肠化生发生率在6%至25%之间。与长段巴雷特食管(LSBE)患者不同,胃食管反流病在SSBE和贲门SIM发病机制中的作用存在争议。最近的数据表明,贲门SIM的病因可能继发于幽门螺杆菌感染,尽管不能排除其他环境因素的作用。在西方国家,过去15年中食管和食管胃交界(EGJ)腺癌的发病率一直在上升。手术系列研究和基于人群的研究表明,到1994年,食管腺癌占白人男性所有食管癌的一半。LSBE和SSBE易患食管和EGJ腺癌。贲门SIM作为EGJ腺癌前体病变的作用仍不清楚。LSBE和SSBE中发育异常的患病率分别约为6%和8%。LSBE患者中腺癌的发病率约为每100患者年1例。SSBE和贲门SIM的癌症风险尚不清楚。吸烟和肥胖会增加食管和EGJ腺癌的风险。